1. Home
  2. SNGX vs MYSZ Comparison

SNGX vs MYSZ Comparison

Compare SNGX & MYSZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • MYSZ
  • Stock Information
  • Founded
  • SNGX 1987
  • MYSZ 1999
  • Country
  • SNGX United States
  • MYSZ Israel
  • Employees
  • SNGX N/A
  • MYSZ N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • MYSZ Computer Software: Prepackaged Software
  • Sector
  • SNGX Health Care
  • MYSZ Technology
  • Exchange
  • SNGX Nasdaq
  • MYSZ Nasdaq
  • Market Cap
  • SNGX 7.4M
  • MYSZ 8.2M
  • IPO Year
  • SNGX 1987
  • MYSZ N/A
  • Fundamental
  • Price
  • SNGX $2.34
  • MYSZ $1.87
  • Analyst Decision
  • SNGX
  • MYSZ Strong Buy
  • Analyst Count
  • SNGX 0
  • MYSZ 1
  • Target Price
  • SNGX N/A
  • MYSZ $3.00
  • AVG Volume (30 Days)
  • SNGX 620.7K
  • MYSZ 228.7K
  • Earning Date
  • SNGX 03-14-2025
  • MYSZ 03-31-2025
  • Dividend Yield
  • SNGX N/A
  • MYSZ N/A
  • EPS Growth
  • SNGX N/A
  • MYSZ N/A
  • EPS
  • SNGX N/A
  • MYSZ N/A
  • Revenue
  • SNGX $364,183.00
  • MYSZ $9,632,000.00
  • Revenue This Year
  • SNGX N/A
  • MYSZ $35.62
  • Revenue Next Year
  • SNGX $76.64
  • MYSZ $12.88
  • P/E Ratio
  • SNGX N/A
  • MYSZ N/A
  • Revenue Growth
  • SNGX N/A
  • MYSZ 43.89
  • 52 Week Low
  • SNGX $1.83
  • MYSZ $1.05
  • 52 Week High
  • SNGX $14.88
  • MYSZ $9.40
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 36.12
  • MYSZ 43.13
  • Support Level
  • SNGX $2.23
  • MYSZ $1.86
  • Resistance Level
  • SNGX $2.39
  • MYSZ $2.30
  • Average True Range (ATR)
  • SNGX 0.17
  • MYSZ 0.26
  • MACD
  • SNGX 0.01
  • MYSZ -0.04
  • Stochastic Oscillator
  • SNGX 22.12
  • MYSZ 12.12

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About MYSZ My Size Inc.

My Size Inc is a USA based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers, and licensing cloud-enabled software subscriptions, associated software maintenance and support.

Share on Social Networks: